Company: PGEN
Filing Date: 2025-03-19
Form Type: 10-K
Source: 0001356090-25-000007
Chunk: 219

Company: PRECIGEN, INC.
Filing Date: 2025-03-19
Form: 10-K
Item: Item 12
Chunk 219
---
 Ended December 31, 2024, 2023, and 2022 

(Amounts in thousands)202420232022Net (loss) income$(126,235)$(95,904)$28,317 Other comprehensive income (loss):Unrealized gain (loss) on investments43 727 (431)Gain (loss) on foreign currency translation adjustments(999)814 (3,262)Release of cumulative foreign currency translation adjustments to net loss from discontinued operations2,915 — — Comprehensive (loss) income  $(124,276)$(94,363)$24,624 

The accompanying notes are an integral part of these consolidated financial statements.

F-8

Precigen, Inc. and Subsidiaries

Consolidated Statements of Mezzanine Equity and Shareholders' Equity

Years Ended December 31, 2024, 2023, and 2022 

(Amounts in thousands, except share data)Mezzanine Stock Common StockTreasury StockAdditionalPaid-inCapitalAccumulatedOtherComprehensive(Loss) Income AccumulatedDeficitTotalShareholders'EquitySharesAmountSharesAmountSharesAmountBalances at December 31, 2021— $— 206,739,874 $— — $— $2,022,701 $203 $(1,915,556)$107,348 Cumulative effect of adoption of ASU 2020-06— — — — — — (36,868)— 18,672 (18,196)Stock-based compensation expense— — — — — — 10,207 — 10,207 Shares issued upon vesting of restricted stock units and for exercises of stock options — — 354,089 — — — 1 — — 1 Shares issued for accrued compensation— — 772,071 — — — 1,698 — — 1,698 Shares issued as payment for services— — 283,987 — — — 575 — — 575 Net income— — — — — — — — 28,317 28,317 Other comprehensive loss— — — — — — — (3,691)— (3,691)Balances at